(Q37206175)

18 August 2017

1 reference

title

New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools (English)

1 reference

18 August 2017

0 references

0 references

0 references

1

Marie-Alice Meuwis

0 references

Marie-Paule Merville

6

object named as

Marie-Paule Merville

0 references

Marianne Fillet

object named as

Marianne Fillet

2

0 references

Edouard Louis

5

object named as

Edouard Louis

1 reference

18 August 2017

Jean-Paul Chapelle

3

1 reference

18 August 2017

Michel Malaise

4

1 reference

18 August 2017

Marie-Paule Merville

6

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

327-337

1 reference

Inflammatory bowel disease: clinical aspects and established and evolving therapies

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Review article: Crohn's disease: monitoring disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Diagnostics of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

C-reactive protein as a marker for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Increased aggregation response of platelets in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Identification of a novel bacterial sequence associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

The value of serologic markers in indeterminate colitis: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Microarrays and Crohn's disease: collecting reliable information

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Technology insight: the application of proteomics in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Proteomics and chronic inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Reproducibility in protein profiling by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Proteome analysis in the clinical chemistry laboratory: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Proteomic mass spectra classification using decision tree based ensemble methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Nanotechnologies in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Analytical nanobiotechnology for medicine diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

AFM fishing nanotechnology is the way to reverse the Avogadro number in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Pancreatic Autoantibodies in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.327

21 January 2018

Identifiers

DOI

10.1586/14737159.8.3.327

1 reference

18 August 2017

1 reference